Spontaneous and inducible production of leukaemia inhibitory factor by human bone marrow stromal cells

V Lorgeot1, F Rougier, P Fixe

  • 1Laboratoire d'Hématologie Expérimentale,, Faculté de Médecine, 2 rue Dr. Marcland, Limoges, 87025, France.

Cytokine
|November 5, 1997
PubMed

Insights

Human bone marrow stromal cells produce leukaemia inhibitory factor (LIF). Cytokines like IL-1 and TNF-alpha stimulate LIF production, suggesting stromal cells are a key source of this growth factor in bone marrow.

Area of Science:

  • Hematology
  • Cell Biology
  • Immunology

Background:

  • Leukaemia inhibitory factor (LIF) is crucial for hematopoietic cell growth and differentiation.
  • Understanding the source and regulation of LIF in the bone marrow microenvironment is essential.

Purpose of the Study:

  • To investigate whether human bone marrow stromal cells produce LIF.
  • To identify factors that regulate LIF synthesis in these cells.

Main Methods:

  • Enzyme-linked immunosorbent assay (ELISA) was used to quantify human LIF.
  • Stromal cells were stimulated with various cytokines and agents, including lipopolysaccharide (LPS), phorbol 12-myristate 13-acetate (PMA), and specific interleukins.
  • Protein kinase C (PKC) dependency was assessed using specific inhibitors.

Main Results:

  • Human bone marrow stromal cells were confirmed to produce LIF.
  • LIF synthesis was dose-dependently enhanced by LPS and PMA.
  • PMA-induced LIF production was dependent on PKC, as shown by inhibition with sphingosine and staurosporine.
  • Several cytokines, including IL-1α, IL-1β, IL-3, IL-6, IL-8, TNF-α, and SCF, stimulated LIF production.
  • M-CSF, G-CSF, GM-CSF, bFGF, PAF, PGE2, LTB4, and LTC4 did not stimulate LIF production.

Conclusions:

  • Human bone marrow stromal cells are a significant source of LIF.
  • LIF production by stromal cells is regulated by various cytokines and signaling pathways, including PKC.
  • These findings highlight the role of stromal cells in cytokine-mediated LIF production within the bone marrow.

Related Concept Videos

Lineage Commitment01:21

Lineage Commitment

Commitment is the  process whereby stem cells:
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Production of Formed Elements01:34

Production of Formed Elements

Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...